|
Following the receipt of updated shares in issue information for Teva Pharmaceutical (Israel), FTSE announces the following changes:
| INDEX |
CHANGE |
EFFECTIVE FROM
START OF TRADING |
| FTSE Med 100 Index |
Teva Pharmaceutical (Israel, 6882172) will remain in the index with an increased shares in issue figure of 947,588,311 and an unchanged investability weighting of 100%. |
24 March 2014 |
For index related enquiries or further information about FTSE please contact:
| Client Services in UK: |
Tel: +44 (0) 20 7866 1810 |
| Client Services in US: |
Tel: +1 888 747 FTSE (3873) or +1 212 314 1139 |
| Client Services in Asia Pacific: |
Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com
|
